← Open Payments lookup

MORGAN NOBLE: Open Payments

NPI 1285244178 · MANILA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$496 in 24 payments from 12 companies in 2025. Trend: 2023 $542 · 2024 $682 · 2025 $496

Food & beverage: $496
CompanyPaymentsAmount
Insulet Corporation3$76
ABBVIE INC.3$67
AstraZeneca Pharmaceuticals LP3$65
Novo Nordisk Inc4$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
Otsuka America Pharmaceutical, Inc.2$43
Axsome Therapeutics, Inc.2$42
Sumitomo Pharma America, Inc.1$24
Verona Pharma, Inc.1$21
GlaxoSmithKline, LLC.1$15

Products named: Omnipod, CAPLYTA, Ozempic, REXULTI, Auvelity, FARXIGA, QULIPTA, GEMTESA.

Industry payments across AR — which companies pay providers there.